Literature DB >> 9869753

Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy.

J J Nigro1, J A Hagen, T R DeMeester, S R DeMeester, J H Peters, S Oberg, J Theisen, M Kiyabu, P F Crookes, C G Bremner.   

Abstract

OBJECTIVE: The purpose of this study was to characterize the prevalence and location of regional lymph node metastases in adenocarcinoma confined to the esophagal wall, to determine the extent of dissection required, and to investigate the applicability of nonoperative therapy.
METHODS: Histologic evaluation of the resected specimens after en bloc esophagogastrectomy with mediastinal and abdominal lymphadenectomy was performed on 37 patients with adenocarcinoma confined to the esophageal wall. Follow-up was complete in all patients (median 24 months).
RESULTS: Fifteen patients (41%) had intramucosal tumors. Twelve (32%) had submucosal tumors and 10 (27%) had muscular invasion. The prevalence of regional lymph node metastases (15/37 patients, 41%) increased progressively with depth of tumor invasion, with involved nodes identified in 80% of patients with muscular invasion. Lymph node metastases were also more common at distant node stations in intramuscular tumors (5/10, 50%). Actuarial survival for the entire group was 63% at 5 years. Recurrence was identified in 6 of the 37 patients (16%), with the risk of recurrence correlating with tumor depth.
CONCLUSIONS: Tumor depth is a strong predictor of the probabilities of regional lymph node metastases, the likelihood of involvement of distant node groups, and the risk of recurrence. Patients with invasion of the muscular wall are at particularly high risk. En bloc esophagectomy with mediastinal and abdominal lymphadenectomy has the highest likelihood of achieving an R0 resection. The long-term survival and low recurrence rate achieved with an en bloc esophagectomy emphasizes the importance of an aggressive lymph node dissection to remove all potentially involved nodes.

Entities:  

Mesh:

Year:  1999        PMID: 9869753     DOI: 10.1016/s0022-5223(99)70464-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  41 in total

Review 1.  Antireflux surgery in the management of Barrett's esophagus.

Authors:  T R DeMeester
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

Review 2.  Pattern of lymphatic spread of Barrett's cancer.

Authors:  Marcus Feith; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

3.  Measurement of the tumor invasion depth into the submucosa in early adenocarcinoma of the esophagus (pT1b): Can microns be the new standard for the endoscopist?

Authors:  Hendrik Manner; Oliver Pech
Journal:  United European Gastroenterol J       Date:  2015-12       Impact factor: 4.623

4.  Extended endoscopic mucosal resection in the esophagus and hypopharynx: a new rigid device.

Authors:  Yves Jaquet; Raphaelle Pilloud; Pierre Grosjean; Alexandre Radu; Philippe Monnier
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-17       Impact factor: 2.503

5.  Endoscopic mucosal resection in the setting of Barrett's esophagus.

Authors:  Jason K Lee; Robert Enns
Journal:  Can J Gastroenterol       Date:  2007-03       Impact factor: 3.522

6.  Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus.

Authors:  Ganapathy A Prasad; Kenneth K Wang; Kevin C Halling; Navtej S Buttar; Louis-Michel Wongkeesong; Alan R Zinsmeister; Shannon M Brankley; Emily G Barr Fritcher; Wytske M Westra; Kausilia K Krishnadath; Lori S Lutzke; Lynn S Borkenhagen
Journal:  Gastroenterology       Date:  2008-05-07       Impact factor: 22.682

7.  Endoscopic mucosal resection for gastroesophageal cancer in a U.K. population. Long-term follow-up of a consecutive series.

Authors:  Andrew B C Crumley; James J Going; Kerryanne McEwan; Margaret McKernan; Jo-Etienne Abela; Christopher J Shearer; Adrian J Stanley; Robert C Stuart
Journal:  Surg Endosc       Date:  2010-07-10       Impact factor: 4.584

Review 8.  [Surgical strategy for early stage carcinoma of the esophagus].

Authors:  N Niclauss; M Chevallay; J L Frossard; S P Mönig
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

9.  Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus.

Authors:  Michael F Nentwich; Katharina von Loga; Matthias Reeh; Faik G Uzunoglu; Andreas Marx; Jakob R Izbicki; Dean Bogoevski
Journal:  J Gastrointest Surg       Date:  2013-10-04       Impact factor: 3.452

10.  Minimally invasive esophagectomy.

Authors:  Christy M Dunst; Lee L Swanström
Journal:  J Gastrointest Surg       Date:  2009-09-30       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.